Login
Breaking News
Moderna   Lululemon   U.S. PPI   Signet Jewelers   KB Home   JP Morgan Chase   U.S. CPI   Target Corp.   UnitedHealth  

Pmv pharmaceuticals inc.

Biotechnology:-Biological-Products-(No-Diagnostic-Substances)

PMVP



,
Investor Relation

Executive/
Director

Executive/Director

Links

10K
10Q
Prospectus

Price

  • Last Close
  • $ 1.55
    $ +0.03 1.64 %
    Jan 3, 2025
  • 52-Week High/Low
  • $7.32 - $1.23
  • YTD
  • 2.6%

  • Trading Volume
  • 4,507
  • Market Cap Full
  • $ 75.1M
  • Shares Outstanding
  • 48.5M
    Aug 7, 2023

Returns +
Q

2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -44.8% -6.1% -45.2% -44.8% 2.7%
Q2 - - - - 4% 3.9% -34.3% 31.2% -6.7% -
Q3 - - - - 8% -12.8% -16.5% -1.9% -4.8% -
Q4 - - - - 67.9% -22.5% -26.9% -47.8% -15.2% -

Returns +
M
J F M A M J J A S O N D
2025 2.7% - - - - - - - - - - -
2024 -43.2% 5.1% -7.6% -5.9% 11.8% -7.8% 1.2% -4.8% - - - -10.1%

Returns +
A
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-61%-62%-64%-51%3%

Earnings

2018 2019 2020 2021 2022 2023
Q1 - - - -0.26 -0.41 -0.42
Q2 - - - -0.29 -0.38 -0.38
Q3 - - - -0.33 -0.4 -0.34
Q4 - - - -0.4 -0.42 -
A 0 0 -2.4 -1.3 -1.6 -1.14

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Outstanding Shares
(In Millions) +

Jan 16, 2024
2020 2021 2022 2023
Mar - 44.8 45.5 45.8
Jun - 45 45.6 45.8
Sep - 45.3 45.6 48.5
Dec 44.8 45.4 45.7 -

Financial Statements
+

Annual
Download

SEC Filings

Date Form Type SEC Filings
Oct 3, 2024 4 Financial Statements
Sep 12, 2024 4 Financial Statements
Aug 14, 2024 SC TO-I/A Financial Statements
Aug 8, 2024 10-Q Financial Statements
Aug 8, 2024 8-K Financial Statements
Jul 16, 2024 SC TO-I Financial Statements
Jul 8, 2024 SC 13G/A Financial Statements
Jun 10, 2024 4 Financial Statements
Jun 7, 2024 8-K Financial Statements
Apr 9, 2024 SC 13G/A Financial Statements

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 19.3 - 35 13.5 19
Equity multiplier 0.1 0.1 - - -
Data Sources Disclaimer